These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study. Allardet-Servent J; Castanier M; Signouret T; Soundaravelou R; Lepidi A; Seghboyan JM Crit Care Med; 2015 Dec; 43(12):2570-81. PubMed ID: 26488219 [TBL] [Abstract][Full Text] [Related]
25. Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy. Pasko DA; Churchwell MD; Salama NN; Mueller BA Blood Purif; 2011; 32(2):82-8. PubMed ID: 21372565 [TBL] [Abstract][Full Text] [Related]
26. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309 [TBL] [Abstract][Full Text] [Related]
27. Sampling from Extracorporeal Circuit: A Step Forward for Dose Monitoring in Continuous Renal Replacement Therapy. Ruffa MC; Bocciero V; Fabbri S; Nencini F; Fanelli A; Romagnoli S; Ricci Z; Cauda V; Villa G Blood Purif; 2024; 53(3):181-188. PubMed ID: 37992698 [TBL] [Abstract][Full Text] [Related]
28. Modalities of continuous renal replacement therapy: technical and clinical considerations. Cerdá J; Ronco C Semin Dial; 2009; 22(2):114-22. PubMed ID: 19426413 [TBL] [Abstract][Full Text] [Related]
29. Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro Results. Jang SM; Shieh JJ; Riley IR; Dorshow RB; Mueller BA ASAIO J; 2023 Jul; 69(7):702-707. PubMed ID: 37071749 [TBL] [Abstract][Full Text] [Related]
30. Continuous renal replacement therapy: evolution in technology and current nomenclature. Ronco C; Bellomo R Kidney Int Suppl; 1998 May; 66():S160-4. PubMed ID: 9573595 [TBL] [Abstract][Full Text] [Related]
31. [The effect of continuous high-volume hemofiltration therapy on TNF-alpha of pancreatitis patients complicated with acute renal function failure]. Li ZJ; Xu YQ; Wang HM; Chen W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jul; 19(4):373-5. PubMed ID: 15163389 [TBL] [Abstract][Full Text] [Related]
32. Use of in vitro models of haemofiltration and haemodiafiltration to estimate dosage regimens for critically ill patients prescribed cefpirome. Phillips GJ; Davies JG; Olliff CJ; Kingswood C; Street M J Clin Pharm Ther; 1998 Oct; 23(5):353-9. PubMed ID: 9875683 [TBL] [Abstract][Full Text] [Related]
36. Innovative techniques to decrease blood exposure and minimize interruptions in pediatric continuous renal replacement therapy. Eding DM; Jelsma LR; Metz CJ; Steen VS; Wincek JM Crit Care Nurse; 2011 Feb; 31(1):64-71. PubMed ID: 21285465 [TBL] [Abstract][Full Text] [Related]
37. Continuous renal replacement therapy in sepsis and multisystem organ failure. Joannidis M Semin Dial; 2009; 22(2):160-4. PubMed ID: 19426421 [TBL] [Abstract][Full Text] [Related]
38. Continuous renal replacement therapy does not have a clear role in the treatment of poisoning. Kim Z; Goldfarb DS Nephron Clin Pract; 2010; 115(1):c1-6. PubMed ID: 20173343 [TBL] [Abstract][Full Text] [Related]